Immix Biopharma, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Immix Biopharma, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Immix Biopharma, Inc. Assets for the quarter ending September 30, 2024 was $25.1M, a 11.9% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$25.1M	+$2.67M	+11.9%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$28.8M	+$13.3M	+85.2%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$34.3M	+$21.1M	+160%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$19.9M	+$5.02M	+33.7%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$22.5M	+$5.08M	+29.2%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$15.6M	-$3.52M	-18.4%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$13.2M	-$6.81M	-34%	Mar 31, 2023	10-Q	2023-05-12
Q4 2022	$14.9M	-$3.28M	-18.1%	Dec 31, 2022	10-K	2024-03-29
Q3 2022	$17.4M			Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$19.1M			Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$20M			Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$18.2M	+$17.7M	+3271%	Dec 31, 2021	10-K	2023-03-27
Q4 2020	$540K			Dec 31, 2020	10-K	2022-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.